Significant Events and Transactions - Clinical programs (Details)			1 Months Ended
	Oct. 22, 2024 criteria Candidates regulatory patch component	Jul. 31, 2023 study	Jun. 30, 2022 Candidates	Mar. 31, 2021 patch
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of patches | patch				5
Number of additional safety study | study		2
Subsequent event
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of patches | patch	1
Number of qualifying criteria | criteria	3
Number of study component | component	2
Number of local country regulatory health authorities | regulatory	2
Epitope Toddlers Study
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of candidates in active treatment development program			362
Epitope Toddlers Study | Active
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of candidates in active treatment development program			244
Epitope Toddlers Study | Placebo
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of candidates in active treatment development program			118
Comfort Toddlers Safety Study | Subsequent event
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total number of candidates covered by the study	600
Comfort Toddlers Safety Study | Minimum | Subsequent event
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of additional candidates covered by the study	300
Comfort Toddlers Safety Study | Maximum | Subsequent event
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of additional candidates covered by the study	350
Comfort Children Safety Study | Subsequent event
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of additional candidates covered by the study	250
Total number of candidates covered by the study	600